Rheumatology and psychiatry: allies in times of COVID-19

Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S. Alarcón, Manuel Francisco Ugarte Gil

Research output: Contribution to journalReview articlepeer-review


The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients’ quality of life can be substantially improved.

Original languageEnglish
JournalClinical Rheumatology
StateAccepted/In press - 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2021, International League of Associations for Rheumatology (ILAR).


  • Coronavirus disease 2019
  • COVID-19
  • Mental health
  • Psychiatrists
  • Rheumatic diseases
  • Rheumatologists

Fingerprint Dive into the research topics of 'Rheumatology and psychiatry: allies in times of COVID-19'. Together they form a unique fingerprint.

Cite this